VeriMombarley sh-oligopeptide-1 hamilelikte güvenli mi?
No evidence of reproductive or developmental hazard was identified in authoritative sources. There is no harmonised CLP classification (ECHA Annex VI) for reproductive toxicity for 'barley sh-oligopeptide-1', no SCCS or CIR safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenicity or endocrine disruption in PubMed. Peptides of this type are large biomolecules with low systemic absorption after topical application, so exposure is expected to be negligible for pregnancy.
Pregnancy-safe products containing barley sh-oligopeptide-1
Related ingredients
Frequently asked questions
- barley sh-oligopeptide-1 hamilelikte güvenli mi?
- No evidence of reproductive or developmental hazard was identified in authoritative sources. There is no harmonised CLP classification (ECHA Annex VI) for reproductive toxicity for 'barley sh-oligopeptide-1', no SCCS or CIR safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenicity or endocrine disruption in PubMed. Peptides of this type are large biomolecules with low systemic absorption after topical application, so exposure is expected to be negligible for pregnancy.
- barley sh-oligopeptide-1 emzirirken güvenli mi?
- No data indicate reproductive or lactation hazards. No harmonised classification or authoritative safety assessment (CIR/SCCS) indicates risk to breastfeeding; no peer‑reviewed evidence shows milk transfer or effects on lactation. Topical peptides are unlikely to achieve systemic levels sufficient to transfer into breast milk.
- barley sh-oligopeptide-1 bebek cildi için güvenli mi?
- No evidence of developmental or dermal toxicity in infants. Mechanistic concerns are not documented. However, infants (0–3 yr) have a higher skin permeability and higher surface‑area‑to‑weight ratio, so exposure potential is higher than in adults; adult dermal absorption for large oligopeptides is expected to be negligible, but given immature barrier function a conservative exposure score of 1 is applied. No infant‑specific adverse reports were found.
- VeriMom barley sh-oligopeptide-1 nasıl puanlıyor?
- VeriMom barley sh-oligopeptide-1'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte barley sh-oligopeptide-1 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.